Gene · 2072
Papers3,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Safeguarding DNA Replication: A Golden Touch of MiDAS and Other Mechanisms. | Int J Mol Sci | 2022 | 36232633 | PubTator, text mining | PubMed |
| Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer. | Cancers (Basel) | 2022 | 36230796 | PubTator, text mining | PubMed |
| ERCC1 Overexpression Increases Radioresistance in Colorectal Cancer Cells. | Cancers (Basel) | 2022 | 36230725 | PubTator, text mining | PubMed |
| TRF1 uses a noncanonical function of TFIIH to promote telomere replication. | Genes Dev | 2022 | 36229075 | PubTator, text mining | PubMed |
| The UHRF protein family in epigenetics, development, and carcinogenesis. | Proc Jpn Acad Ser B Phys Biol Sci | 2022 | 36216533 | PubTator, text mining | PubMed |
| Observing protein dynamics during DNA-lesion bypass by the replisome. | Front Mol Biosci | 2022 | 36213113 | PubTator, text mining | PubMed |
| Nucleases and Co-Factors in DNA Replication Stress Responses. | DNA (Basel) | 2022 | 36203968 | PubTator, text mining | PubMed |
Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations. | Ther Adv Med Oncol | 2022 | 36199621 | PubTator, text mining | PubMed |
| A protein with broad functions: damage-specific DNA-binding protein 2. | Mol Biol Rep | 2022 | 36190612 | PubTator, text mining | PubMed |
| Single-molecule fluorescence imaging techniques reveal molecular mechanisms underlying deoxyribonucleic acid damage repair. | Front Bioeng Biotechnol | 2022 | 36185427 | PubTator, text mining | PubMed |
| XPF activates break-induced telomere synthesis. | Nat Commun | 2022 | 36184605 | PubTator, text mining | PubMed |
| An overview of resistance to chemotherapy in osteosarcoma and future perspectives. | Cancer Drug Resist | 2022 | 36176756 | PubTator, text mining | PubMed |
| Ovarian cancer resistance to PARPi and platinum-containing chemotherapy. | Cancer Drug Resist | 2022 | 36176755 | PubTator, text mining | PubMed |
| Early-onset ophthalmoplegia, cervical dyskinesia, and lower extremity weakness due to partial deletion of chromosome 16: A case report. | World J Clin Cases | 2022 | 36159412 | PubTator, text mining | PubMed |
| Construction of Molecular Subtype and Prognosis Prediction Model of Osteosarcoma Based on Aging-Related Genes. | J Oncol | 2022 | 36157228 | PubTator, text mining | PubMed |
| Effects of replication domains on genome-wide UV-induced DNA damage and repair. | PLoS Genet | 2022 | 36155646 | PubTator, text mining | PubMed |
| Radiochemotherapy-induced DNA repair promotes the biogenesis of gastric cancer stem cells. | Stem Cell Res Ther | 2022 | 36153608 | PubTator, text mining | PubMed |
| Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients. | Cancers (Basel) | 2022 | 36139606 | PubTator, text mining | PubMed |
| Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses. | Oncologist | 2022 | 36124924 | PubTator, text mining | PubMed |
| Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients. | Front Oncol | 2022 | 36119527 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2072/papers?page=24